Details of the Drug
General Information of Drug (ID: DMGD0HT)
Drug Name |
Tellurium
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Tellurium; 13494-80-9; Telloy; Tellur; Aurum paradoxum; Tellurium element; Tellur [Polish]; Metallum problematum; Tellurium, metallic; Tellurium, elemental; Tellurium Atom; UNII-NQA0O090ZJ; Tellurium and compounds; HSDB 2532; NCI-C60117; EINECS 236-813-4; NQA0O090ZJ; teluro; Tellurium, 99+%, (trace metal basis), powder; Tellurium, 99.999%, (trace metal basis), powder; tellure; Tellurium compounds, n.o.s.; Tellurium, 99.8%, (trace metal basis), powder, -200 mesh; Tellurium powder; Tellurium compounds; ACMC-1BQVR; 52Te; EC 236-813-4
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 |
Molecular Weight | 127.6 | ||||||||||||||||||
Topological Polar Surface Area | Not Available | |||||||||||||||||||
Rotatable Bond Count | 0 | |||||||||||||||||||
Hydrogen Bond Donor Count | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count | 0 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References